Disorders of consciousness

Published on 27/02/2015 by admin

Filed under Anesthesiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 2864 times

Chapter 42 Disorders of consciousness

NEUROANATOMY AND PHYSIOLOGY OF WAKEFULNESS

A normal level of consciousness depends on the interaction between the cerebral hemispheres and the rostral reticular activating system (RAS) located in the upper brainstem. Although the RAS is a diffuse projection, the areas of RAS of particular importance to the maintenance of consciousness are those located between the rostral pons and the diencephalon. In contrast, consciousness is not focally represented in any of the cerebral hemispheres and is in many ways related to the mass of functioning cortex. Thus anatomical bilateral hemispheric lesions or brainstem lesions may result in an altered conscious state.1 Large unilateral hemispheric lesions may produce impairment of consciousness by compression of the upper brainstem. In addition metabolic processes may result in coma from interruption of energy substrate delivery or alteration of neuronal excitability. Disorders of consciousness are characterised by an alteration in either the level or content of consciousness (Table 42.1). The last few conditions described in Table 42.1 are a frequent source of confusion and require further discussion (Table 42.2). These neurological states are seen more frequently in modern-day clinical practice partly because of the advances in therapy of severe brain injury and intensive care which have led to the survival of many patients who would otherwise have died.

Table 42.1 Disorders of consciousness

Consciousness An awake individual demonstrates full awareness of self and environment
Confusion Inability to think with customary speed and clarity, associated with inattentiveness, reduced awareness and disorientation
Delirium Confusion with agitation and hallucination
Stupor Unresponsiveness with arousal only by deep and repeated stimuli
Coma Unarousable unresponsiveness
Locked-in syndrome Total paralysis below third cranial nerve nuclei; normal or impaired mental function
Persistent vegetative state Prolonged coma > 1 month, some preservation of brainstem and motor reflexes
Akinetic mutism Prolonged coma with apparent alertness and flaccid motor tone
Minimally conscious state Preserved wakefulness, awareness and brainstem reflexes, but poorly responsive

CLINICAL EXAMINATION OF THE COMATOSE PATIENT

The neurological examination of the comatose patient is of crucial importance to assess the depth of coma and to locate the site of lesion. Although the detailed neurological examination which can be carried out in a conscious patient is not possible in a comatose individual, useful information can be obtained by performing a thorough general examination and a neurological examination, particularly evaluating the level of consciousness, brainstem signs and motor responses in coma.

LEVEL OF CONSCIOUSNESS

This is assessed by the Glasgow Coma Scale (GCS),2 which takes into account a patient’s response to command and physical stimuli. The GCS (Table 42.4) which was originally developed to grade the severity of head injury and prognosticate outcome, has now been extended for all causes of impaired consciousness and coma. Although it is a simple clinical score, easily performed by both medical and nursing staff by the bedside, there are a number of caveats:

Table 42.4 Glasgow Coma Scale

Eye opening Points
Spontaneous 4
To speech 3
To pain 2
Nil 1
Best verbal response
Oriented 5
Confused 4
Inappropriate 3
Incomprehensible 2
Nil 1
Intubated T
Best motor response
Obeys commands 6
Localises to pain 5
Withdraws to pain 4
Abnormal flexion 3
Extensor response 2
Nil 1

PUPILLARY RESPONSES IN COMA3

The presence of normal pupils (2–5 mm and equal in size and demonstrating both direct and consensual light reflexes) confirms the integrity of the pupillary pathway (retina, optic nerve, optic chiasma and tracts, midbrain and third cranial nerve nuclei and nerves). The size of the pupil is a balance between the opposing influences of both sympathetic (causing dilatation) and parasympathetic (causing constriction) systems. Pupillary abnormalities have localising and diagnostic value in clinical neurology (Table 42.5). When the pupils are miosed, the light reaction is difficult to appreciate and may require a magnifying glass.

Table 42.5 Pupillary abnormalities in coma

Abnormality Cause Neuroanatomical basis
Miosis (< 2 mm in size)
Unilateral Horner’s syndrome Sympathetic paralysis
  Local pathology Trauma to sympathetics
Bilateral Pontine lesions  
  Thalamic haemorrhage Sympathetic paralysis
  Metabolic encephalopathy  
  Drug ingestion  
  Organophosphate Cholinesterase inhibition
  Barbiturate  
  Narcotics Central effect
Mydriasis (> 5 mm in size)
Unilateral fixed pupil Midbrain lesion Third-nerve damage
  Uncal herniation Stretch of third nerve against the petroclinoid ligament
Bilateral fixed pupils Massive midbrain haemorrhage Bilateral third-nerve damage
  Hypoxic cerebral injury Drugs Mesencephalic damage
  Atropine Paralysis of parasympathetics
  Tricyclics Prevent local reuptake of catecholamines by nerve endings
  Sympathomimetics Stimulation of sympathetics

EYE MOVEMENTS IN COMA5

Horizontal eye movements to the contralateral side are initiated in the ipsilateral frontal lobe and closely coordinated with the corresponding centre in the contralateral pons. To facilitate conjugate eye movements, yoking of the third-, fourth- and sixth-nerve nuclei is achieved by the medial longitudinal fasciculus.

To look to the left, the movement originates in the right frontal lobe and is coordinated by the left pontine region and vice versa. In contrast to horizontal gaze, vertical eye movements are under bilateral control of the cortex and upper midbrain.

The position and movements of the eyes are observed at rest. The presence of spontaneous roving eye movements excludes brainstem pathology as a cause of coma. In a paralytic frontal-lobe pathology, the eyes will deviate towards the side of the lesion, whilst in pontine pathologies, the eyes will deviate away from the side of the lesion. Ocular bobbing, an intermittent downward jerking eye movement, is seen in pontine lesions due to loss of horizontal gaze and unopposed midbrain controlled vertical gaze activity.6 Skew deviation (vertical separation of the ocular axes) occurs with pontine and cerebellar disorders.7

The presence of full and conjugate eye movements in response to oculocephalic and oculovestibular stimuli demonstrates the functional integrity of a large segment of the brainstem. Corneal reflexes are preserved until late in coma. Upward rolling of the eyes after corneal stimulation (Bell’s phenomenon) implies intact midbrain and pontine function.

RESPIRATORY SYSTEM8

Abnormal respiratory rate and patterns have been described in coma, but their precise localising value is uncertain. As a general rule, at lighter levels of impaired consciousness tachypnoea predominates, whereas respiratory depression increases with the depth of coma. Some of the commonly observed respiratory abnormalities are summarised in Table 42.6. Respiratory failure in comatose patients may result from hypoventilation, aspiration pneumonia and neurogenic pulmonary oedema, a sympathetic nervous system-mediated syndrome seen in acute brain injury.

Table 42.6 Disorders of respiratory rate and pattern in coma

Abnormality Significance
Bradypnoea Drug-induced coma, hypothyroid coma
Tachypnoea Central neurogenic hyperventilation (midbrain lesion),
  metabolic encephalopathy
Cheyne–Stokes respiration Deep cerebral lesions, metabolic encephalopathy (hyperpnoea alternating regularly with apnoea)
Apneustic breathing (an inspiratory pause) Pontine lesions
Ataxic breathing Medullary lesions
(Ataxic breathing normally progresses to agonal gasps and terminal apnoea)

MANAGEMENT OF THE COMATOSE PATIENT

EMERGENT THERAPEUTIC MEASURES

Irrespective of the aetiology of coma, certain emergent therapeutic measures apply to the care of all patients. These take precedence over any diagnostic investigation.

3 Administer 50% dextrose after drawing a sample of blood for serum glucose levels. Although there are theoretical concerns about augmentation of brain lactic acid production11,12 in anoxic coma, the relatively good prognosis for hypoglycaemic coma when treated expeditiously far outweighs any potential risks of glucose administration.

NEUROIMAGING

COMPUTED TOMOGRAPHY (CT) SCAN

The most commonly used radiological investigation for evaluation of the comatose patient is CT scan of the brain. This is useful for diagnosing central nervous system trauma, subarachnoid and intracerebral haemorrhage, haemorrhagic and non-haemorrhagic strokes, cerebral oedema, hydrocephalus and the presence of a space-occupying lesion (SOL) (Figures 42.142.10). Frequently a CT is performed prior to a lumbar puncture (LP) to exclude rather than confirm the presence of severe cerebral oedema or an SOL. Its other advantages include lower cost, easy availability, short examination time and safety in the presence of pacemakers, surgical clips and other ferromagnetic substances. The advent of helical CT whereby multiple images are possible has reduced scanning times and is suitable for the uncooperative patient. Limitations of a CT scan include:

MAGNETIC RESONANCE IMAGING (MRI)

MRI scans provide superior contrast and resolution of the grey and white matter as compared to CT scans, thus facilitating easy identification of the deep nuclear structures within the brain. MRI is more sensitive than CT for the detection of acute ischaemia, diffuse axonal injury and cerebral oedema, tumour and abscess. Brainstem and posterior fossa structures are better visualised (Figures 42.1142.13). It can also show vasculature (see Figure 42.13b and c). The other advantage of MRI is the use of non-ionising energy. The use of gadolinium, a paramagnetic agent, as a contrast agent permits sharp definition of lesions. MR coupled with angiography (MRA) may enable diagnosis of vascular lesions. MRI is however limited by:

ELECTROENCEPHALOGRAM (EEG) IN COMA15,16

The usefulness of EEG in coma is summarised in Table 42.7. Continuous EEG monitoring in the intensive care unit (ICU) has been reported to be useful in the identification of acute cerebral ischaemia and non-convulsive seizures.

Table 42.7 Usefulness of electroencephalogram in coma

Identification of non-convulsive status epilepticus
Diagnosis of hepatic encephalopathy
Presence of paroxysmal triphasic waves
Assessing severity of hypoxic encephalopathy
Presence of theta activity
Diffuse slowing
Burst suppression (seen with more severe forms)
Alpha coma (seen with more severe forms)
Herpes encephalitis
Periodic sharp spikes

CARE OF THE COMATOSE PATIENT

ANOXIC COMA/ENCEPHALOPATHY

Cardiac arrest is the third leading cause of coma resulting in ICU admission after trauma and drug overdose. The symptomatology and clinical outcome of patients with anoxic brain damage depend on the severity and duration of oxygen deprivation to the brain. A number of criteria have been developed to prognosticate outcome in anoxic coma. Although a number of laboratory and imaging criteria contribute to the prognostic assessment, clinical signs still have major prognostic impact. The important clinical predictors of outcome are listed in Table 42.8. However there are data to suggest that electrophysiological studies using evoked potential have far greater prognostic accuracy compared to clinical assessment.20

Table 42.8 Clinical and laboratory predictors of unfavourable prognosis in anoxic coma17,3638

Clinical predictor Unfavourable prognosis
Duration of anoxia 8–10 min
(time interval between collapse and initiation of CPR)  
Duration of CPR > 30 min
(time interval between initiation of CPR and ROSC)  
Duration of postanoxic coma > 72 hours
Pupillary reaction Absent on day 3
Motor response to pain (absent = a motor response worse than withdrawal) Absent on day 3
Roving spontaneous eye movements Absent on day 1
Elevated neuron specific enolase > 33 μg/l
SSEP recording Absent N20

CPR, cardiopulmonary resuscitation; ROSC, restoration of spontaneous circulation; SSEP, somatosensory evoked potential.

THE CONFUSED/ENCEPHALOPATHIC PATIENT IN THE ICU

‘Encephalopathy’ is a term used to describe the alteration in the level or content of consciousness due to a process extrinsic to the brain. Metabolic encephalopathy, particularly of septic aetiology, is the most common cause of altered mental status in the ICU setting.21 A number of processes can lead to metabolic encephalopathy (Table 42.9). A number of features in the history and examination help to differentiate metabolic from structural causes of altered conscious states (Table 42.10).

Table 42.9 Aetiology of metabolic/toxic encephalopathy3941

Hepatic failure
Renal failure
Respiratory failure
Sepsis
Electrolyte abnormalities: hyponatraemia, hypernatraemia, hypercalcaemia
Hypoglycaemia and hyperglycaemia
Acute pancreatitis
Endocrine – addisonian crisis, myxoedema coma, thyroid storm
Drug withdrawal – benzodiazepine, opiates
Hyperthermia
Toxins: alcohols, glycols, tricyclic antidepressants
Intensive care unit syndrome
D-lactic acidosis

Table 42.10 Distinguishing features of structural and metabolic encephalopathy41

Feature Structural Metabolic
State of consciousness Usually fixed level of depressed conscious state, may deteriorate progressively Milder alteration of conscious state, waxing and waning of altered sensorium
Fundoscospy May be abnormal Usually normal
Pupils May be abnormal, either in size or response to light Usually preserved light response (although pupil shape and reactivity affected in certain overdoses: see above)
Eye movements May be affected Usually preserved
Motor findings Asymmetrical involvement Abnormalities usually symmetrical
Involuntary movements Not common Asterixis, tremor, myoclonus frequently seen

Owing to their increased frequency in and exclusiveness to the critical care setting, two types of encephalopathy will be considered in detail: septic encephalopathy and ICU syndrome.

Sepsis-associated encephalopathy (SAE) has been reported to occur in 8–80% of patients with sepsis.22 The criteria to diagnose SAE include presence of impaired mental function, evidence of an extracranial infection and absence of other obvious aetiologies for the altered conscious state. Although the precise mechanism of damage to the brain has not been delineated, the pathogenesis of the encephalopathy is thought to be multifactorial: alteration in cerebral blood flow induced by mediators of inflammation, generation of free radicals by activated leukocytes resulting in erythrocyte sludging in the microcirculation, breakdown of the blood–brain barrier resulting in cerebral oedema, reduced brain oxygen consumption induced by endotoxin and cytokines, neuronal degeneration and increased neuronal apoptosis, increases in aromatic amino acids resulting in altered neurotransmitter function and increased gamma-aminobutyric acid (GABA)-mediated neurotransmission leading to general inhibition of the central nervous system. Hypotension may contribute to the encephalopathy. The asterixis, tremor and myoclonus – features of other metabolic encephalopathies – are uncommon in sepsis. The presence of lateralising signs are extremely rare in SAE and warrant exclusion of other causes, such as stroke. The mortality of patients with SAE is higher than in those with sepsis without encephalopathy.23 Therapy is largely directed at the underlying septic process.

PROGNOSIS IN COMA

Drug-induced comas usually have a good prognosis unless hypoxia and hypotension have resulted in severe secondary insults. Coma following head injury has a statistically better outcome compared to non-traumatic coma (coma occurring during the course of a medical illness). In non-traumatic coma lasting for 6 hours or greater, only 15% of the patients make a meaningful recovery to be able to return to their premorbid state of health.28 The prognosis following anoxic coma has been described in a separate section. Within the non-traumatic coma category, coma resulting from infection, metabolic causes and multiple-organ dysfunction syndrome has a better outcome compared to anoxic coma.29 A number of outcome scales have been developed to assess neurological recovery following brain injury.30 These include the Barthel index, Rankin scale and the Glasgow Outcome Scale (GOS). The GOS is widely used to assess recovery after traumatic brain injury. It has five broad categories: 1 = good recovery; 2 = moderate disability; 3 = severe disability; 4 = persistent vegetative state; and 5 = death. It is simple, easy to administer and has been reported to have good interrater agreement.

REFERENCES

1 Ropper A, Martin J. Coma and other disorders of consciousness. In: Isselbacher K, editor. Harrison’s Principles of Internal Medicine. McGraw Hill; 1994:146-152.

2 Teasdale G, Jennett B. Assessment of coma and impaired consciousness. A practical scale. Lancet. 1974;2:81-84.

3 Adams R, Victor M, Ropper A. Coma and related disorders of consciousness. In: Principles of Neurology. McGraw Hill; 1997:344-366.

4 Keane JR. Retinal hemorrhages. Its significance in 100 patients with acute encephalopathy of unknown cause. Arch Neurol. 1979;36:691-694.

5 Keane J. Eye movements in coma. In: Jakbiec AA, editor. Principles and Practice of Ophthalmology. WB Saunders; 2000:4075-4083.

6 Fisher C. Ocular bobbing. Arch Neurol. 1964;11:543.

7 Keane JR. Ocular skew deviation. Analysis of 100 cases. Arch Neurol. 1975;32:185-190.

8 North JB, Jennett S. Abnormal breathing patterns associated with acute brain damage. Arch Neurol. 1974;31:338-344.

9 Kernohan J, Woltman H. Incisura of the crus due to contralateral brain tumour. Arch Neurol Psych. 1929;21:274.

10 McNealy D, Plum F. Brainstem dysfunction with supratentorial mass lesions. Arch Neurol. 1962;7:10.

11 De Salles AA, Muizelaar JP, Young HF. Hyperglycemia, cerebrospinal fluid lactic acidosis, and cerebral blood flow in severely head-injured patients. Neurosurgery. 1987;21:45-50.

12 Penney DG. Hyperglycemia exacerbates brain damage in acute severe carbon monoxide poisoning. Med Hypotheses. 1988;27:241-244.

13 Van Den Berk G, Tonino S, De Fjtjer C. Bench to bedside review: preventive measures for contrast induced nephropathy in critically ill patients. Crit Care. 2005;9:361-370.

14 Venkatesh B, Scott P, Ziegenfuss M. Cerebrospinal fluid in critical illness. Crit Care Resuscit. 2000;2:43-55.

15 Bauer G. Coma and brain death. Niedermeyer E, Da Silva F, editors. Electroencephalogrpahy: Basic Principles, Clinical Applications and Related Fields. 1999, 459-475.

16 Nuwer MR. Continuous EEG monitoring in the intensive care unit. Electroencephalogr Clin Neurophysiol. 1999;50(Suppl):150-155.

17 Zandbergen EG, de Haan RJ, Stoutenbeek CP, et al. Systematic review of early prediction of poor outcome in anoxic-ischaemic coma. Lancet. 1998;352:1808-1812.

18 Berger RP. The use of serum biomarkers to predict outcome after traumatic brain injury in adults and children. J Head Trauma Rehabil. 2006;21:315-333.

19 Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma. 1993;34:216-222.

20 Kaplan PW. Electrophysiological prognostication and brain injury from cardiac arrest. Semin Neurol. 2006;26:403-412.

21 Stevens RD, Pronovost PJ. The spectrum of encephalopathy in critical illness. Semin Neurol. 2006;26:440-451.

22 Wilson JX, Young GB. Progress in clinical neurosciences: sepsis associated encephalopathy: evolving concepts. Can J Neurol Sci. 2003;30:98-105.

23 Eidelman LA, Putterman D, Putterman C, et al. The spectrum of septic encephalopthy. Definiitons, etiologies and mortalities. JAMA. 1996;275:470-473.

24 McGuire BE, Basten CJ, Ryan CJ, et al. Intensive care unit syndrome: a dangerous misnomer. Arch Intern Med. 2000;160:906-909.

25 Pun BT, Ely EW. The importance of diagnosing and managing ICU delirium. Chest. 2007;132:624-636.

26 Granberg Axell AI, Malmross CW, Bergbom IL, et al. Intensive care unit syndrome/delirium is associated with anemia, drug therapy and duration of ventilation. Acta Anaesthesiol Scand. 2002;46:726-731.

27 Shilo L, Dagan Y, Smorjik Y, et al. Patients in the intensive care unit suffer from severe lack of sleep associated with loss of normal melatonin secretion pattern. Am J Med Sci. 1999;317:278-281.

28 Plum F, Levy DE. Outcome from severe neurological illness; should it influence medical decisions? Ciba Found Symp. 1979;69:267-277.

29 Levy DE, Bates D, Caronna JJ, et al. Prognosis in nontraumatic coma. Ann Intern Med. 1981;94:293-301.

30 Kasner SE. Clinical interpetation and use of stroke scales. Lancet Neurol. 2006;5:603-612.

31 Nordgren RE, Markesbery WR, Fukuda K, et al. Seven cases of cerebromedullospinal disconnection: the ‘locked-in’ syndrome. Neurology. 1971;21:1140-1148.

32 Multi Society Task Force on PVS. Medical aspects of the persistent vegetative state (1). N Engl J Med. 1994;330:1499-1508.

33 Jennett B, Plum F. Persistent vegetative state after brain damage. A syndrome in search of a name. Lancet. 1972;1:734-737.

34 Cairns H, Oldfield R, Pennybacker K. Akinetic mutism with an epidermoid cyst of the third ventricle. Brain. 1941;64:273.

35 Stevens RD, Bhardwaj A. Approach to the comatose patient. Crit Care Med. 2006;34:31-41.

36 Berek K, Jeschow M, Aichner F. The prognostication of cerebral hypoxia after out-of-hospital cardiac arrest in adults. Eur Neurol. 1997;37:135-145.

37 Levy DE, Caronna JJ, Singer BH, et al. Predicting outcome from hypoxic–ischemic coma. JAMA. 1985;253:1420-1426.

38 Wijducks EF, Hijdra A, Young GB, et al. Practice parameter; prediction of outcome in comatose survivors after cardiopulmonary resuscitation (an evidence based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2006;67:203-210.

39 Surtees R, Leonard JV. Acute metabolic encephalopathy: a review of causes, mechanisms and treatment. J Inherit Metab Dis. 1989;12(Suppl. 1):42-54.

40 Uribarri J, Oh MS, Carroll HJ. D-lactic acidosis. A review of clinical presentation, biochemical features, and pathophysiologic mechanisms. Medicine (Baltimore). 1998;77:73-82.

41 Plum F. Sustained impairment of consciousness. In: Bennett CPF, editor. Cecil Textbook of Medicine. WB Saunders; 1996:1970-1978.